Product Details

SERETIDE 50MCG/250MCG DISKUS INHALATION POWDER#

Fluticasone Propionate; Salmeterol (Salmeterol Xinafoate)
250 mcg/Metered-Dose; 50 mcg/Metered-Dose
Inhalation powder

ROA

Inhalation

Applicant Name

Glaxo Smithkline Consumer Nigeria PLC

NRN

04-3323

Status

Active

SMPC

Composition

ATC Code

R03AK06

Product Category

Drugs

Marketing Category

Prescription-only Medicine (POM)

Packsize

1*60

Product Description

SERETIDE 50MCG/250MCG DISKUS INHALATION POWDER SALMETEROL AND FLUTICASONE PROPIONATE (Active Ingredients - Salmeterol (as xinafonate) 72.5µg & Fluticasone propionate 250µg) (Other ingredients- Lactose Monohydrate - 12.5mg) Apr-23 Drugs Imported Products 1*60 Prescription Only Medicine (POM) 02/03/2020 GLAXOSMITHKLINE PHARMACEUTICAL NIGERIA LTD., INDUSTRIAL AVENUE ILUPEJU LAGOS 12711000 delphine.u.onyeaso@gsk.com GlaxoSmithKline LLC,1011 North Arendell Avenue,Zebulon ,North Carolina USA, GlaxoSmithKline LLC,1011 North Arendell Avenue ,Zebulon,North Carolina USA, United States

Manufacturer Name

GlaxoSmithKline LLC

Manufacturer Country

UNITED STATES OF AMERICA

Approval Date

2023-07-06

Expiry Date

2028-07-05